Cargando…
What is community pharmacists’ level of comfort and interest in managing patients with or at risk of major neurocognitive disorders?
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647402/ https://www.ncbi.nlm.nih.gov/pubmed/36386608 http://dx.doi.org/10.1177/17151635221128552 |
_version_ | 1784827374313930752 |
---|---|
author | Murugesu, Khaarthikaa Massé, Olivier Maheu, Anne Guénette, Line |
author_facet | Murugesu, Khaarthikaa Massé, Olivier Maheu, Anne Guénette, Line |
author_sort | Murugesu, Khaarthikaa |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9647402 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-96474022022-11-15 What is community pharmacists’ level of comfort and interest in managing patients with or at risk of major neurocognitive disorders? Murugesu, Khaarthikaa Massé, Olivier Maheu, Anne Guénette, Line Can Pharm J (Ott) Research and Clinical SAGE Publications 2022-10-13 /pmc/articles/PMC9647402/ /pubmed/36386608 http://dx.doi.org/10.1177/17151635221128552 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Research and Clinical Murugesu, Khaarthikaa Massé, Olivier Maheu, Anne Guénette, Line What is community pharmacists’ level of comfort and interest in managing patients with or at risk of major neurocognitive disorders? |
title | What is community pharmacists’ level of comfort and interest in
managing patients with or at risk of major neurocognitive
disorders? |
title_full | What is community pharmacists’ level of comfort and interest in
managing patients with or at risk of major neurocognitive
disorders? |
title_fullStr | What is community pharmacists’ level of comfort and interest in
managing patients with or at risk of major neurocognitive
disorders? |
title_full_unstemmed | What is community pharmacists’ level of comfort and interest in
managing patients with or at risk of major neurocognitive
disorders? |
title_short | What is community pharmacists’ level of comfort and interest in
managing patients with or at risk of major neurocognitive
disorders? |
title_sort | what is community pharmacists’ level of comfort and interest in
managing patients with or at risk of major neurocognitive
disorders? |
topic | Research and Clinical |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647402/ https://www.ncbi.nlm.nih.gov/pubmed/36386608 http://dx.doi.org/10.1177/17151635221128552 |
work_keys_str_mv | AT murugesukhaarthikaa whatiscommunitypharmacistslevelofcomfortandinterestinmanagingpatientswithoratriskofmajorneurocognitivedisorders AT masseolivier whatiscommunitypharmacistslevelofcomfortandinterestinmanagingpatientswithoratriskofmajorneurocognitivedisorders AT maheuanne whatiscommunitypharmacistslevelofcomfortandinterestinmanagingpatientswithoratriskofmajorneurocognitivedisorders AT guenetteline whatiscommunitypharmacistslevelofcomfortandinterestinmanagingpatientswithoratriskofmajorneurocognitivedisorders |